Circular RNA‐based neoantigen vaccine for hepatocellular carcinoma immunotherapy

Documenti analoghi

• CREB3 suppresses hepatocellular carcinoma progression by depressing AKT signaling through competitively binding with insulin receptor and transcriptionally activating RNA‐binding motif protein 38
  di: Yi He, et al.
  Pubblicazione: (2024)
• An inflammatory liquid fingerprint predicting tumor recurrence after liver transplantation for hepatocellular carcinoma
  di: Modan Yang, et al.
  Pubblicazione: (2024)
• Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy
  di: Xiaoting Luo, et al.
  Pubblicazione: (2024)
• A novel small molecule ZYZ384 targeting SMYD3 for hepatocellular carcinoma via reducing H3K4 trimethylation of the Rac1 promoter
  di: Qian Ding, et al.
  Pubblicazione: (2024)
• Natural killer cells in cancer immunotherapy
  di: DanRu Wang, et al.
  Pubblicazione: (2024)